Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Desmond Gilmartin"'
Autor:
Lisa Nwankwo, Desmond Gilmartin, Sheila Matharu, Ali Nuh, Jackie Donovan, Darius Armstrong-James, Anand Shah
Publikováno v:
Journal of Fungi, Vol 8, Iss 4, p 362 (2022)
Background: Instances of resistant fungal infection are rising in pulmonary disease, with limited therapeutic options. Therapeutic drug monitoring of azole antifungals has been necessary to ensure safety and efficacy but is considered unnecessary for
Externí odkaz:
https://doaj.org/article/8f06d75b87e3464d81ed7ca59bc46581
Autor:
Lisa Nwankwo, Jimstan Periselneris, Desmond Gilmartin, Sujal Desai, Anand Shah, Vasilis Kouranos, Elisabetta Renzoni, Athol Wells, Phil Molyneaux, Peter George, M. Kokosi, Anand Devaraj, Darius Armstrong-James, Felix Chua
Publikováno v:
Medical Mycology. 60
Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Introduction Aspergillosis complicating pulmonary sarcoidosis is associated with high mortality.1 The specific prognostic impact of fibrocavitary sarcoid disease, however, remains poorly unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba6780080469a35083a586e395f631e4
https://doi.org/10.1093/mmy/myac072.p249
https://doi.org/10.1093/mmy/myac072.p249
Autor:
Simone Borsci, Alberto Vidal-Diez, Desmond Gilmartin, Anand Shah, Nicholas J. Simmonds, Presanna Premachandra, Wai Y Tang, Emily Frost, Lise Gillen, Julie Wilkins, Melody Ni, Jonny Harcourt, Lorenzo Picinali, Kate McLaren, Deborah J. Morris-Rosendahl, Caroline Elston, Anitha Vijayasingam
Publikováno v:
Thorax, 75(8):214177, 632-639. BMJ Publishing Group
IntroductionIndividuals with chronic lung disease (eg, cystic fibrosis (CF)) often receive antimicrobial therapy including aminoglycosides resulting in ototoxicity. Extended high-frequency audiometry has increased sensitivity for ototoxicity detectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd2b66b74abe3b2f2bbdb0f6394febc
http://www.scopus.com/inward/record.url?scp=85085173958&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85085173958&partnerID=8YFLogxK
Autor:
Lisa Nwankwo, Desmond Gilmartin, Sheila Matharu, Ali Nuh, Jackie Donovan, Darius Armstrong-James, Anand Shah
Background: The burden of resistant fungal infection is rising in patients with pulmonary disease. Options for antifungal therapy are limited, and the only orally-available antifungals, the triazoles, demonstrate inter and intra-patient variability,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d441a77e571f65b35dd00734390971a9
https://doi.org/10.20944/preprints202202.0194.v1
https://doi.org/10.20944/preprints202202.0194.v1
